Hi Traders! CADJPY Technical Analysis and Short Term Forecast Hey there fellow traders! Today we’re diving into the world of CADJPY technical analysis and sharing our short term forecast with you. As always, we’re using the trusty MetaTrader4 platform (MT4) for our analysis. And hey, we’ve got some insider tips and hacks about the MT4…
OMNIQ CORP Receives Initial Purchase Order from Major US Fast-Food Chain SALT LAKE CITY, Aug. 11, 2022 (GLOBE NEWSWIRE) — OMNIQ CORP (NASDAQ: OMQS), a leading provider of Supply Chain and Artificial Intelligence (AI)-based Machine Vision solutions, has announced the receipt of an initial purchase order from a Major American Casual Fast-Food Chain with over…
Guardion Health Sciences Announces Highest Quarterly Revenue in Company History Viactiv® Product Line Drives Growth Guardion Health Sciences, Inc. (Nasdaq: GHSI) has reported record-breaking revenue of approximately $3.275 million for the most recent quarter. This marks a significant increase from the previous quarter and showcases the company’s continued growth and success in the market. Company…
Progress and Challenges in Current Economic Environment The Current State of Inflation and Interest Rates There’s good news on the month-to-month data, showing some signs of improvement in economic indicators. However, inflation remains far too high and is still not near our price stability goal. This is why we can’t afford to declare victory on…
OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants Exciting News in Pediatric Orthopedics WARSAW, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) has recently made a significant announcement that has captured the attention of the medical community and investors alike. The Company has commenced an…
Hey there, fellow cancer warriors! Let’s talk about iTeos Reports Second Quarter 2022 Financial Results and Business Update So, iTeos has been bustling with activity lately, enrolling patients left and right in their Phase 2 trial expansions. One of the exciting developments is the evaluation of anti-TIGIT monoclonal antibody, EOS-448/GSK4428859A, in combination with GSK’s anti-PD-1…
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis Witty, Conversational Blog Post Article: Hey there, lovely readers! Have you heard the latest buzz in the medical world? Rani Therapeutics has just released some exciting news about their Phase 1 study of RT-102 in treating osteoporosis. And let me tell…
Aerojet Rocketdyne Delivers THAAD’s 800th Boost Motor and Divert and Attitude Control System HUNTSVILLE, Ala., Aug. 10, 2022 (GLOBE NEWSWIRE) — Aerojet Rocketdyne has delivered the 800th Solid Rocket Boost Motor and the 800th Divert and Attitude Control System (DACS) for the Terminal High Altitude Area Defense (THAAD) weapon system. THAAD is one of the…
